Last quarter (Q2 2025), ImmunoPrecise Antibodies's total revenue was $6.13M, a decrease of -0.41% from the same quarter last year. In Q2, ImmunoPrecise Antibodies's net income was $-2.55M. See ImmunoPrecise Antibodies’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Apr 24	Apr 23	Apr 22	Apr 21	Apr 20
Total Revenue	$ 24.07M	$ 24.52M	$ 20.66M	$ 19.36M	$ 17.91M	$ 14.06M
Cost of Revenue	$ 11.97M	$ 12.46M	$ 9.10M	$ 8.38M	$ 6.37M	$ 6.02M
Gross Profit	$ 12.10M	$ 12.05M	$ 11.56M	$ 10.98M	$ 11.54M	$ 8.03M
Operating Expense	$ 26.60M	$ 26.15M	$ 37.51M	$ 27.66M	$ 15.71M	$ 11.86M
Operating Income	$ -14.51M	$ -14.09M	$ -25.94M	$ -16.67M	$ -4.18M	$ -3.83M
Net Non Operating Interest Income Expense	$ -610.00K	$ 4.00K	$ 92.00K	$ -194.00K	$ 581.00K	$ 1.39M
Other Income Expense	$ -200.00K	$ -331.00K	$ -332.00K	$ 631.00K	$ -1.24M	$ -82.00K
Pretax Income	$ -30.12M	$ -28.70M	$ -27.75M	$ -15.85M	$ -6.00M	$ -5.29M
Tax Provision	$ -2.58M	$ -1.53M	$ 1.19M	$ 861.00K	$ 1.34M	$ -346.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -27.54M	$ -27.18M	$ -28.94M	$ -16.71M	$ -7.34M	$ -4.95M
Basic EPS	$ -1.03	$ -1.06	$ -1.07	$ -0.85	$ -0.45	$ -1.75
Diluted EPS	$ -1.03	$ -1.06	$ -1.07	$ -0.85	$ -0.45	$ -1.75
Basic Average Shares	$ 107.71M	$ 25.64M	$ 24.90M	$ 19.69M	$ 16.47M	$ 2.73M
Diluted Average Shares	$ 107.71M	$ 25.64M	$ 24.90M	$ 19.69M	$ 16.47M	$ 2.73M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 38.58M	$ 38.61M	$ ―	$ 36.04M	$ -22.09M	$ -17.88M
Net Income From Continuing And Discontinued Operation	$ -27.54M	$ -27.18M	$ -28.94M	$ -16.71M	$ -7.34M	$ -4.95M
Normalized Income	$ -17.67M	$ -15.20M	$ -17.94M	$ -11.76M	$ -4.40M	$ -4.58M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -29.86M	$ -28.70M	$ -27.75M	$ -15.76M	$ -5.13M	$ -3.86M
EBITDA	$ -24.16M	$ -22.97M	$ -21.07M	$ -11.99M	$ -1.42M	$ -449.00K

Currency in USD

ImmunoPrecise Antibodies Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing